Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy

BackgroundThe purpose of this study was set to investigate the prognostic role of plasmatic levels of heat shock protein 90 alpha (HSP90α) at diagnosis in advanced lung cancer patients treated with Programmed cell death protein 1 (PD-1)/Programmed cell death-Ligand protein 1 (PD-L1) inhibitors plus...

Descrición completa

Detalles Bibliográficos

Principais autores:	Shubin Chen, Qitao Yu, Shaozhang Zhou
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Oncology
Assuntos:	advanced lung cancer HSP90α PD-1/PD-L1 inhibitors chemotherapy prognostic marker
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2021.765115/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!